Contacto

medicina regenerativa

medicina regenerativa

Te acompañamos en cada paso
Array ( [0] => WP_Term Object ( [term_id] => 804 [name] => corporate finace tecnológico [slug] => corporate-finace-tecnologico [term_group] => 0 [term_taxonomy_id] => 804 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 8 [filter] => raw ) [1] => WP_Term Object ( [term_id] => 153 [name] => global corporate finance [slug] => global-corporate-finance [term_group] => 0 [term_taxonomy_id] => 153 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 597 [filter] => raw ) [2] => WP_Term Object ( [term_id] => 133 [name] => Health Care [slug] => health-care [term_group] => 0 [term_taxonomy_id] => 133 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) [3] => WP_Term Object ( [term_id] => 1284 [name] => medicina regenerativa [slug] => medicina-regenerativa [term_group] => 0 [term_taxonomy_id] => 1284 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) )
Análisis inversión en sector de FinTech para la gestión de gastos de negocios. Captio y Certify.
Analizamos desde el punto de vista del corporate finance, la compra de Captio -la startup española que gestiona aquello [...]
seguir leyendo >>
Análisis inversión en medicina regenerativa. Histocell y Cell Innovation Partners
Analizamos desde el corporate finance, el caso de Histocell empresa biofarmacéutica centrada en el desarrollo de medica [...]
seguir leyendo >>
closechevron-downcrossmenuchevron-down